{"id":997737,"date":"2026-08-25T07:14:36","date_gmt":"2026-08-25T11:14:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\/"},"modified":"2026-08-25T07:14:36","modified_gmt":"2026-08-25T11:14:36","slug":"oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\/","title":{"rendered":"Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit"},"content":{"rendered":"<p>        <!--body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit<\/b><\/p>\n<p>SAN DIEGO&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nThe Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in Aardvark Therapeutics, Inc. (NASDAQ: AARD) shares in the U.S. District Court for the Southern District of California (No: 3:26-cv-04643).<\/p>\n<p>\nInvestors, who purchased a significant amount of Aardvark Therapeutics, Inc. (NASDAQ: AARD) between February 13, 2025 and May 14, 2026, in excess of $100,000 have certain options and there are short and strict deadlines running. Deadline: October 31, 2026. NASDAQ: AARD investors should contact the Shareholders Foundation at <a rel=\"nofollow\" href=\"mailto:mail@shareholdersfoundation.com\">mail@shareholdersfoundation.com<\/a> or call +1(858) 779 &#8211; 1554.<\/p>\n<p>\nOn August 14, 2024, an investor in NASDAQ: AARD shares filed lawsuit against Aardvark Therapeutics, Inc. The plaintiff alleges that the Offering Documents that were filed in the Company\u2019s February 13, 2025 initial public offering (\u201cIPO\u201d) and that between February 13, 2025 and May 14, 2026 the Defendants made false and\/or misleading statements and\/or failed to disclose that ARD-101 was less safe than the Defendants had led investors to believe, that accordingly, ARD-101\u2019s clinical, regulatory, and commercial prospects were overstated, and that as a result, the Defendants\u2019 public statements were materially false and misleading at all relevant times.<\/p>\n<p>\nThose who purchased NASDAQ: AARD shares should contact the Shareholders Foundation, Inc.<\/p>\n<p>\nThe Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock\/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and\/or settlements are not filed\/initiated\/reached and\/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260825465435r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260825465435\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260825465435\/en\/<\/a><\/span><\/p>\n<p>\nShareholders Foundation, Inc.<br \/>\n<br \/>Michael Daniels<br \/>\n<br \/>+1 (858) 779-1554<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:mail@shareholdersfoundation.com\">mail@shareholdersfoundation.com<br \/>\n<\/a><br \/>3111 Camino Del Rio North<br \/>\n<br \/>Suite 423<br \/>\n<br \/>San Diego, CA 92108<\/p>\n<p><b>KEYWORDS:<\/b> California United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Class Action Lawsuit Professional Services Legal<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260825465435\/en\/2881981\/3\/Shareholders_Foundation_Logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit SAN DIEGO&#8211;(BUSINESS WIRE)&#8211; The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in Aardvark Therapeutics, Inc. (NASDAQ: AARD) shares in the U.S. District Court for the Southern District of California (No: 3:26-cv-04643). Investors, who purchased a significant amount of Aardvark Therapeutics, Inc. (NASDAQ: AARD) between February 13, 2025 and May 14, 2026, in excess of $100,000 have certain options and there are short and strict deadlines running. Deadline: October 31, 2026. NASDAQ: AARD investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 &#8211; 1554. On August 14, 2024, an &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-997737","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit SAN DIEGO&#8211;(BUSINESS WIRE)&#8211; The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in Aardvark Therapeutics, Inc. (NASDAQ: AARD) shares in the U.S. District Court for the Southern District of California (No: 3:26-cv-04643). Investors, who purchased a significant amount of Aardvark Therapeutics, Inc. (NASDAQ: AARD) between February 13, 2025 and May 14, 2026, in excess of $100,000 have certain options and there are short and strict deadlines running. Deadline: October 31, 2026. NASDAQ: AARD investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 &#8211; 1554. On August 14, 2024, an &hellip; Continue reading &quot;Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-25T11:14:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260825465435r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit\",\"datePublished\":\"2026-08-25T11:14:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\\\/\"},\"wordCount\":379,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260825465435r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\\\/\",\"name\":\"Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260825465435r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-08-25T11:14:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260825465435r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260825465435r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\/","og_locale":"en_US","og_type":"article","og_title":"Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit - Market Newsdesk","og_description":"Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit SAN DIEGO&#8211;(BUSINESS WIRE)&#8211; The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in Aardvark Therapeutics, Inc. (NASDAQ: AARD) shares in the U.S. District Court for the Southern District of California (No: 3:26-cv-04643). Investors, who purchased a significant amount of Aardvark Therapeutics, Inc. (NASDAQ: AARD) between February 13, 2025 and May 14, 2026, in excess of $100,000 have certain options and there are short and strict deadlines running. Deadline: October 31, 2026. NASDAQ: AARD investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 &#8211; 1554. On August 14, 2024, an &hellip; Continue reading \"Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-25T11:14:36+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260825465435r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit","datePublished":"2026-08-25T11:14:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\/"},"wordCount":379,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260825465435r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\/","name":"Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260825465435r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-08-25T11:14:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260825465435r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260825465435r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oct-31st-deadline-alert-investors-who-lost-money-with-aardvark-therapeutics-inc-nasdaq-aard-shares-should-contact-the-shareholders-foundation-in-connection-with-lawsuit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/997737","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=997737"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/997737\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=997737"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=997737"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=997737"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}